Cell Line : CP50-MEL-B
Cellosaurus Index : CVCL_1143
Cellosaurus ID : CP50-MEL-B
GDSC1 Name
, GDSC2 Name
: CP50-MEL-B
CCLE Name
: CP50MELB_SKIN
Cancer Type : skin
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| CP50-MEL-B | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| CP50-MEL-B | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CP50-MEL-B | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CP50-MEL-B | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| CP50-MEL-B | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| CP50-MEL-B | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| CP50-MEL-B | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| CP50-MEL-B | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| CP50-MEL-B | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| CP50-MEL-B | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| CP50-MEL-B | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CP50-MEL-B | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| CP50-MEL-B | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CP50-MEL-B | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| CP50-MEL-B | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| CP50-MEL-B | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| CP50-MEL-B | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| CP50-MEL-B | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| CP50-MEL-B | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| CP50-MEL-B | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| CP50-MEL-B | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| CP50-MEL-B | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| CP50-MEL-B | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| CP50-MEL-B | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| CP50-MEL-B | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| CP50-MEL-B | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| CP50-MEL-B | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| CP50-MEL-B | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| CP50-MEL-B | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| CP50-MEL-B | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| CP50-MEL-B | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| CP50-MEL-B | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| CP50-MEL-B | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| CP50-MEL-B | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| CP50-MEL-B | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| CP50-MEL-B | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| CP50-MEL-B | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| CP50-MEL-B | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| CP50-MEL-B | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| CP50-MEL-B | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| CP50-MEL-B | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| CP50-MEL-B | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| CP50-MEL-B | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| CP50-MEL-B | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CP50-MEL-B | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| CP50-MEL-B | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| CP50-MEL-B | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| CP50-MEL-B | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | HG-6-71-01 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| CP50-MEL-B | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| CP50-MEL-B | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| CP50-MEL-B | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| CP50-MEL-B | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CP50-MEL-B | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| CP50-MEL-B | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| CP50-MEL-B | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| CP50-MEL-B | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CP50-MEL-B | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| CP50-MEL-B | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| CP50-MEL-B | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| CP50-MEL-B | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| CP50-MEL-B | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| CP50-MEL-B | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | NG-25 | GDSC1 | 0.0391 | 10.2400 |
|
| CP50-MEL-B | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| CP50-MEL-B | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| CP50-MEL-B | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| CP50-MEL-B | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| CP50-MEL-B | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| CP50-MEL-B | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| CP50-MEL-B | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| CP50-MEL-B | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | Pevonedistat | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| CP50-MEL-B | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| CP50-MEL-B | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| CP50-MEL-B | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| CP50-MEL-B | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| CP50-MEL-B | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | QL-XII-47 | GDSC1 | 0.0391 | 10.2400 |
|
| CP50-MEL-B | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| CP50-MEL-B | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| CP50-MEL-B | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| CP50-MEL-B | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| CP50-MEL-B | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| CP50-MEL-B | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| CP50-MEL-B | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| CP50-MEL-B | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| CP50-MEL-B | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| CP50-MEL-B | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CP50-MEL-B | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| CP50-MEL-B | THZ-1-87 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| CP50-MEL-B | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | THZ-2-98-01 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| CP50-MEL-B | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| CP50-MEL-B | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | torin2 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| CP50-MEL-B | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| CP50-MEL-B | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | UNC0638 | GDSC1 | 0.0781 | 40.0000 |
|
| CP50-MEL-B | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| CP50-MEL-B | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| CP50-MEL-B | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| CP50-MEL-B | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| CP50-MEL-B | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| CP50-MEL-B | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| CP50-MEL-B | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| CP50-MEL-B | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CP50-MEL-B | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| CP50-MEL-B | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CP50-MEL-B | XMD11-50 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| CP50-MEL-B | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| CP50-MEL-B | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| CP50-MEL-B | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| CP50-MEL-B | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CP50-MEL-B | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC